2019 Hepatitis C Genotypes and Treatment

2019 HCV Genotypes and Treatment
Offered on this page is news and research articles with a focus on treating HCV according to genotype using FDA approved medicines. Information is extracted from news articles, peer-reviewed journals, as well as liver meetings/conferences, research manuscripts and interactive learning activities.


Archives
Research Articles
Current full-text articles covering every aspect of HCV

HCV Guidance Updates
The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America with the International Antiviral Society developed a living document with ever evolving guidelines to treat HCV

The following pages include guidance for management of  treatment-naive patients.
Genotype 1 
Genotype 2 
Genotype 3 
Genotype 4 
Genotype 5 or 6

The following pages include guidance for management of treatment-experienced patients.
Genotype 1 
Genotype 2 
Genotype 3 
Genotype 4 
Genotype 5 or 6 

Stay current with all guideline updates, "click here."

Articles:
January 2019
January 17, 2018

Jan 11, 2019
Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

Ledipasvir Plus Sofosbuvir Safe, Effective in Children Age 6 to 12

Jan 9, 2019
Genotype 3
Hepatitis C Genotype 3 Treated with Shortened Glecapravir/Pibrentasvir 

Of Interest
Jan 2, 2019
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Takeshi Kinbara, Tomoaki Fujikawa, Tsuyoshi Nakayama, Hiroki Yamanoue, Takayuki Kanemaru, Tohru Hashimoto, Ji Hyun Sung, Makoto Kako, Wasaburo Koizumi 

Annals Of Hepatology

Genotype 4
Abdel-Moneim A, et al. Ann Gastroenterol. 2019

Genotype 4
New HCV genotype subtypes present in sub-Saharan Africa

No comments:

Post a Comment